New hires and promotions in the med-tech industry, including: 1health, Biosig, Brainsway, Clineone, Henry Schein One, Inogen, Organogenesis.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Acceleron, Aim Immunotech, Akan, Astrazeneca, Biontech, BMS, Celltrion, Cortexyme, Cytocom, Daiichi Sankyo, Forge Biologics, G1, Jazz, JCR, Pfizer, Pharmsynthez PJSC, Sesen, Signature, Sobi, Targovax, Xenetic.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Addex, Alkido, Anixa, Avexegen, Basilea, Beyond Air, Biomunex, Cannabics, Cend, Clearside, Enzolytics, Hikma, Moderna, Neuren, Nicox, Novavax, Oncoheroes, Onward, Qilu, Recce, Renibus, Sensorion, Shepherd, Tryp.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abeona, Adagio, Bluebird, Clene, Diffusion, Equillium, Gensight, Gyroscope, Histogen, Interna, Kodiak, Lysogene, Metacrine, Monopar, Neoimmunetech, Neuren, Noxxon, Realta, Recce, Regenxbio, Sagent, Synairgen.

Biopharmas raising money in public or private financings, including: Adicet, Aravive, Arcutis, Bio-Path, Biophytis, Cassava, Enlivex, Galmed, Gamida, GT Biopharma, Hepion, Inmed, Iterion, OSE, Vallon.

New hires and promotions in the biopharma industry, including: Alzecure, Arena, Artelo, Coherus, Enosi, Evelo, Freeline, Fusion, Immunocore, Jcyte, Oncology Pharma, Organogenesis, PMV, Strongbridge, Taysha Gene.

The latest global regulatory news, changes and updates affecting biopharma.

Quarterly snapshots from biopharma companies with marketed products, including: GW.

The latest global regulatory news, changes and updates affecting medical devices and technologies, including: FDA cites pivotal study failure for Lutonix 014; HHS adds to PREP Act immunity; Dermal fillers on tap at FDA advisory; GAO urges a pause in VA EHR deployment.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Becton Dickinson.